Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackstone Loan Regulatory News (BGLF)

  • This share is currently suspended. It was suspended at a price of 0.742
  • There is currently no data for BGLF

Share Repurchase Programme

21 Oct 2022 15:39

RNS Number : 7671D
Blackstone Loan Financing Limited
21 October 2022
 

21 October 2022

 

Blackstone Loan Financing Limited

("the Company")

 

Share Repurchase Programme

 

The Company announces that it has appointed its joint brokers Winterflood Investment Trusts and Singer Capital Markets Securities Limited to manage a new irrevocable share repurchase programme (the "Share Repurchase Programme") to buy back ordinary shares within certain pre-set parameters (including the existing discount management policy regarding the repurchase of shares as set out in the Company's prospectus issued on 23 November 2018). This follows the expiry of the previous share repurchase programme on 20 October 2022 (as announced on 28 July 2022). The Share Repurchase Programme will commence today and will run until 20 January 2023.

 

Any shares purchased pursuant to the Share Repurchase Programme will count towards the Company's general buy back authority of 14.99% of the Company's issued share capital, as approved at the Company's 2022 AGM.

 

The Company confirms that it currently has no inside information.

 

 

Enquiries:

 

BNP Paribas

 

01534 709178 / 813873

Singer Capital Markets

James Maxwell / Alaina Wong

 

020 7496 3000

 

Winterflood Investment Trusts

Neil Langford

 

020 3100 0000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSZFLFLLBLXFBD
Date   Source Headline
21st Dec 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
21st Nov 20231:17 pmRNSDIVIDEND CURRENCY ELECTION
21st Nov 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
13th Nov 20234:20 pmRNSQ3 2023 Report and Investor Call
20th Oct 20237:00 amRNSNet Asset Value(s)
20th Oct 20237:00 amRNSDividend Declaration
26th Sep 20237:00 amRNSHalf-year Report
21st Sep 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
15th Sep 20231:21 pmRNSResult of Extraordinary General Meeting
25th Aug 20237:00 amRNSNotice of Extraordinary General Meeting
24th Aug 20234:07 pmRNSDirectorate Change
22nd Aug 20237:00 amRNSNet Asset Value and Publication of Monthly Report
9th Aug 20233:56 pmRNSQ2 2023 Report and Investor Call
26th Jul 20234:29 pmRNSBoard Update
26th Jul 20234:29 pmRNSResult of AGM
21st Jul 20237:00 amRNSNet Asset Value and Publication of Monthly Report
21st Jul 20237:00 amRNSDividend Declaration
10th Jul 20235:21 pmRNSNotice of Annual General Meeting
23rd Jun 20236:09 pmRNSProposed Managed Wind-Down of the Company
22nd Jun 20237:00 amRNSNET ASSET VALUE AND PUBLICATION OF MONTHLY REPORT
23rd May 20237:00 amRNSNet Asset Value and Publication of Monthly Report
11th May 20236:04 pmRNSQ1 2023 Report and Investor Call
28th Apr 20237:00 amRNSAnnual Financial Report
25th Apr 20237:00 amRNSDividend Declaration
25th Apr 20237:00 amRNSNet Asset Value(s)
3rd Apr 20234:54 pmRNSTotal Voting Rights
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSNet Asset Value(s)
17th Mar 20237:00 amRNSResults of Shareholder Consultation
2nd Mar 20235:31 pmRNSTransaction in Own Shares
2nd Mar 20235:08 pmRNSTransaction in Own Shares
1st Mar 20235:11 pmRNSTransaction in Own Shares
1st Mar 20233:05 pmRNSTotal Voting Rights
24th Feb 20234:18 pmRNSDIVIDEND CURRENCY ELECTION
22nd Feb 20237:00 amRNSNet Asset Value and Publication of Monthly Report
10th Feb 20234:48 pmRNSTransaction in Own Shares
10th Feb 20234:12 pmRNSNon-material change to Investment Policy
10th Feb 20231:58 pmRNSQ4 2022 Report and Investor Call
1st Feb 20233:36 pmRNSHolding(s) in Company
1st Feb 20231:10 pmRNSTotal Voting Rights
26th Jan 20239:37 amRNSShareholder Consultation
23rd Jan 20233:13 pmRNSInvestor Call
23rd Jan 202311:38 amRNSShare Repurchase Programme
23rd Jan 20237:00 amRNSDividend Declaration
23rd Jan 20237:00 amRNSNet Asset Value(s)
19th Jan 20234:44 pmRNSTransaction in Own Shares
16th Jan 20235:13 pmRNSHolding(s) in Company
16th Jan 20234:53 pmRNSTransaction in Own Shares
13th Jan 20234:36 pmRNSTransaction in Own Shares
12th Jan 20234:48 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.